跳至主要内容
临床试验/ACTRN12613000666729
ACTRN12613000666729已完成4 期

For healthy volunteers and subjects who undergo colonoscopy, will using Penthrox as a modality of analgesia have little or no effect on psychomotor function because of its minimal sedative effect.

Department of Gastroenterology and Hepatology, Royal Adelaide Hospital0 个研究点目标入组 60 人开始时间: 2013年6月19日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 79 Years(—)
性别
All

入选标准

  • Able to give informed consent
  • Adequate understanding of use of the Penthrox inhaler

排除标准

  • History of significant alcohol (>40gms/d for males, 20gms/d for females) or narcotic use.
  • Previous history of significant cardiac or respiratory illnesses (ie. ischaemic heart disease, chronic obstructive pulmonary disease).
  • Significantly underweight (<45kg)
  • Significant smoking history of more than 20 packs / year.
  • Previous history of gastrointestinal surgery (likely to increase difficulty of colonoscopy)
  • Renal impairment
  • Diabetes Mellitus
  • Previous possible allergy to the medication by the patient or a relative
  • Hypersensitivity to fluorinated agents
  • Previous head injury
  • Difficulty in following instructions (including language barrier)
  • Patients taking any potential nephrotoxic drugs (e.g. aminoglycosides)
  • Malignant hyperthermia

研究者

发起方
Department of Gastroenterology and Hepatology, Royal Adelaide Hospital

相似试验